Jon Snodgres, Chief Financial Officer at REPLIGEN CORP (RGEN), sold 3,818 shares at $34.91 ($133K) on 2017-03-17, disclosed to the SEC on 2017-03-21.
Open-market sale of $133k RGEN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.91 | 1,909 | $67K | 50.0% |
| 2 | $34.91 | 1,909 | $67K | 50.0% |
| Total | $34.91 avg | 3,818 | $133K | 100% |
| Filing → |
| RGEN | SELL | 2022-08-02 | $440K | — | Filing → |
| RGEN | SELL | 2021-05-18 | $81K | — | Filing → |
| RGEN | SELL | 2021-03-08 | $797K | — | Filing → |